Janssen Global Services LLC
At Janssen we are translating our understanding of the biology behind retinal diseases into developing potentially transformational therapies. Janssen’s clinical-stage portfolio seeks to treat a range of eye diseases, including rare inherited retinal diseases x-linked retinitis pigmentosa and achromatopsia, as well as more common conditions, such as age-related macular degeneration, diabetic retinopathy and diabetic macular edema.